CUSIP: 29363K105
Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,936,542
-
Share change
-
+3,668,679
-
Total reported value
-
$233,711,856
-
Price per share
-
$13.80
-
Number of holders
-
67
-
Value change
-
+$48,581,403
-
Number of buys
-
50
-
Number of sells
-
22
Quarterly Holders Quick Answers
What is CUSIP 29363K105?
CUSIP 29363K105 identifies ENTL - ENTELLUS MED INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2017
-
Previous quarter:
Q4 2016
Recent filing periods for CUSIP 29363K105:
Institutional Holders of ENTELLUS MED INC - COM (ENTL) as of Q1 2017
As of 31 Mar 2017,
ENTELLUS MED INC - COM (ENTL) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,936,542 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., SV Health Investors, LLC, Discovery Group I, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, ArrowMark Colorado Holdings LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., BlackRock Inc., and VANGUARD GROUP INC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.